首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備拋棄式

市場調查報告書

商品編碼

2055215

預填充式注射器市場：按材料、藥物類型、設計、產品類型、用途、製造方法、最終用戶和地區分類

Prefilled Syringes Market, By Material, By Drug Type, By Design, By Product Type, By Usability, By Manufacturing Method, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，預填充式注射器市場規模將達到 76 億美元，到 2033 年將達到 112.7 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	76億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	5.80%	2033年市場規模預測：	112.7億美元

預填充式注射器是一種一次性注射器，其內部已預先填充了待注射的藥物。注射器內裝有製造商預先安裝的針頭，用於單次給藥。由於這些注射器已預先填充藥物，護理師和患者無需自行配藥或抽取藥物。正確的劑量已預先填充在注射器內，可實現快速注射。此外，預填充式注射器使用起來更加精準，因此也更加安全。一些預填充式注射器藥筒設計用於可與自吸式注射器配合使用，無需推動活塞即可透過皮下注射給藥。這確保了藥物的順利輸送，並使注射深度達到預期。

市場動態

慢性病盛行率的不斷上升推動了預填充式注射器作為治療方法的需求，預計這將促進預測期內的市場成長。例如，根據美國疾病管制與預防中心 (CDC) 於 2022 年 7 月更新的慢性病數據，美國約有 60% 的成年人患有某種形式的慢性病，超過 40% 的成年人患有兩種或兩種以上的慢性病。癌症是全球最常見的慢性病。例如，根據 GLOBOCAN 2021 年報告，2021 年全球癌症確診病例總數約為 19,292,789 例。預計到 2040 年，這一數字將增至 28,887,940 例。多種癌症正在使用新型藥物和生技藥品進行治療，預計將增加 2026 年至 2033 年預測期內對預填充式注射器的需求。因此，預計全球癌症患者數量的增加將推動預填充式注射器市場在預測期內的成長。

預計在預測期內，市場參與企業利用監管部門批准的藥品數量不斷增加來拓展產品系列，將推動市場成長。例如，2022年12月，跨國製藥公司Alembic Pharmaceuticals Limited宣布，其單劑量預充式注射器（250毫克/5毫升（50毫克/毫升））的氟維司群注射液的簡略新藥申請（ANDA）已獲得美國食品藥物管理局（FDA）的預填充式注射器批准。氟維司群注射液是一種雌激素受體拮抗劑，用於治療乳癌。

本研究的關鍵特徵

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球預填充式注射器市場主要參與者的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
全球預填充式注射器市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球預填充式注射器市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第12章競爭格局

Gerresheimer AG
Becton, Dickinson and Company
West Pharmaceutical Services, Inc.
Terumo Corporation
Nipro Europe Group Companies
B.Braun SE
GSK plc.
Pfizer Inc.
Bayer AG
Polymedicure
Amsino International, Inc.
Leeford Healthcare Limited
Torrent Pharmaceuticals Ltd.
Regeneron Pharmaceuticals Inc.
Ypsomed AG
SOL-Millennium
Stevanato Group SpA

第13章

調查方法
關於本公司

簡介目錄

Product Code: CMI162

Prefilled Syringes Market is estimated to be valued at USD 7.60 Bn in 2026 and is expected to reach USD 11.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.60 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 11.27 Bn

Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.

Market Dynamics

Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2021 report, the total number of people in the world affected by cancer in 2021 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period 2026 - 2033. Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.

The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market

Market Segmentation

Global Prefilled Syringes Market, By Material (Revenue, USD Bn, 2021 - 2033)
Glass
Plastic/Polymer
Global Prefilled Syringes Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
Biologics
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
Vaccines
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
Insulin
Anticoagulants
Flush Saline Syringes
Others
Global Prefilled Syringes Market, By Design (Revenue, USD Bn, 2021 - 2033)
Single-chamber
Dual-chamber
Multi-chambered
Global Prefilled Syringes Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
Staked in-needle pre-filled syringes
Needle-free pre-filled syringes
Global Prefilled Syringes Market, By Usability (Revenue, USD Bn, 2021 - 2033)
Disposable
Reusable
Global Prefilled Syringes Market, By Manufacturing Method (Revenue, USD Bn, 2021 - 2033)
Captive
Merchant
Global Prefilled Syringes Market, By End User (Revenue, USD Bn, 2021 - 2033)
Hospital
Clinics
Ambulatory Surgical Centers
Others
Global Prefilled Syringes Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Gerresheimer AG
Becton, Dickinson and Company
West Pharmaceutical Services, Inc.
Terumo Corporation
Nipro Europe Group Companies
B. Braun SE
Sanofi
GSK plc.
Pfizer Inc.
Bayer AG
Polymedicure
Amsino International, Inc.
Leeford Healthcare Limited
Torrent Pharmaceuticals Ltd.
Regeneron Pharmaceuticals Inc.
Ypsomed AG
SOL-Millennium
Stevanato Group S.p.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Material
- Market Snapshot, By Drug Type
- Market Snapshot, By Design
- Market Snapshot, By Product Type
- Market Snapshot, By Usability
- Market Snapshot, By Manufacturing Method
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
Service Cost Analysis

4. Global Prefilled Syringes Market, By Material, 2026-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Plastic/Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

5. Global Prefilled Syringes Market, By Drug Type, 2026-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
  - Monoclonal Antibodies
  - Blood Products
  - Others (Erythropoietin, Therapeutic proteins, among others)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
  - Conjugated Vaccines
  - Live Attenuated Vaccines
  - Recombinant Vaccines
  - Others (Virus-like particles (VLPs), Viral vector vaccines)
Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Flush Saline Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

6. Global Prefilled Syringes Market, By Design, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Single-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Dual-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Multi-chambered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

7. Global Prefilled Syringes Market, By Product Type, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Staked in-needle pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Needle-free pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

8. Global Prefilled Syringes Market, By Usability, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

9. Global Prefilled Syringes Market, By Manufacturing Method, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Captive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Merchant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

10. Global Prefilled Syringes Market, By End User, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segments Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

11. Global Prefilled Syringes Market, By Region, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

12. Competitive Landscape

Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
West Pharmaceutical Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nipro Europe Group Companies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
B.Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Polymedicure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amsino International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leeford Healthcare Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SOL-Millennium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Stevanato Group S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies